Home › Funds › Viking Global Investors › INBX

Viking Global Investors position in INBX

INHIBRX BIOSCIENCES INC · Health Care

Latest position (Q2 2026)1.12M sh
Reported value held$106.49M
Portfolio Weight0.31%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 5.31M $176.74M New
Q4 2021 5.31M $231.71M Hold
Q1 2022 5.31M $118.22M Hold
Q2 2022 5.31M $60.22M Hold
Q3 2022 5.31M $95.24M Hold
Q4 2022 6.64M $163.59M Add
Q1 2023 6.64M $125.28M Hold
Q2 2023 6.64M $172.35M Hold
Q3 2023 7.15M $131.22M Add
Q4 2023 7.15M $271.73M Hold
Q1 2024 7.15M $249.99M Hold
Q2 2024 1.79M $25.33M Reduce
Q3 2024 1.79M $28.00M Hold
Q4 2024 1.79M $27.53M Hold
Q1 2025 1.79M $25.01M Hold
Q2 2025 1.79M $25.51M Hold
Q3 2025 1.79M $60.21M Hold
Q4 2025 1.44M $113.58M Reduce
Q1 2026 1.44M $96.66M Hold
Q2 2026 1.12M $106.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding INBX

All INBX fund holders →